SALISBURY, Md. — TidalHealth Peninsula Regional has temporarily moved its COVID-19 monoclonal antibody infusion treatment out of the emergency department and inside a tent, which has been constructed near the walk-in entrance. The relocation allows the emergency department staff to expand space and beds, and use the location where the clinic had previously been conducted to address increasing volumes.

If a person tests positive for COVID-19 and feel that the monoclonal antibody infusion may benefit them, they should consult with their primary care provider who can help to determine if they are a good candidate. If one is determined to be a good candidate, their primary care provider must refer them for the monoclonal antibody infusion. The person will be contacted to schedule their appointment.

The treatment is a lab-created protein that mimics immune system antibodies that block viruses. By blocking viral attachment and entry into human cells, it helps to neutralize the virus and reduce the risk of developing severe COVID symptoms.